TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Recording of time awake after sleep onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Acceptability measured by treatment acceptability interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability - Client Satisfaction Questionnaire-8 (CSQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility - participant attrition during the intervention period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Castration-resistant prostate cancer-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Serum Osteocalcin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sleep Variability
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: All stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: unplanned cardiac rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Implicit wanting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intestinal microflora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma taurine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Dose Limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Occurance rate of adverse drug reaction
Endpoint domain: Adverse events/effects
Primary endpoint: 2-year region-free recurrence survival
Endpoint domain: Mortality/survival
Primary endpoint: modified Rankin Scale (mRS) of 0-3 at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in perceptual distortion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: STAI tool (state trait anxiety inventory)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Body awareness questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of kidney allograft
Endpoint domain: Mortality/survival
Primary endpoint: Compliance with visit to Primary Care Physician
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Behavioural change in hypertension prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: passage of access sheath
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Treatment strategy failure (TSF) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve from Time 0 Extrapolated to Infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of functional dyspepsia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean % change in BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pathologically complete response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Harris hip joint function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Clinical Influenza
Endpoint domain: Adverse events/effects
Primary endpoint: Change of pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety and tolerability of LYN-014
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of levomethadone (Cmin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of levomethadone (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of glottic opening (POGO) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Albumin to High-Sensitivity C-Reactive Protein (hsCRP) Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: evaluation of senescence markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA methylation (methylation rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Maternal Heart Rate (MHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Patients Achieving (PPA)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of the visual N-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reaction times of the visual N-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Accuracy of the verbal N-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reaction times of the verbal N-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of patients with medical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Ratings of Perceived Exertion
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Local recurrence prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of early OHSS
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with serious adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with treatment-emergent adverse events (TEAEs) leading to premature discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal ECG readings
Endpoint domain: Adverse events/effects
Primary endpoint: Mental Composite Score (MCS) of KDQOL-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sexual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increase in percentage of patients with targeted antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants who subsequently enroll in another study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in anxiety state scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average time to complete the trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of obstacle collisions during the trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average travel time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S. aureus reservoir detection
Endpoint domain: Adverse events/effects
Primary endpoint: epidemiologically-related transmission event
Endpoint domain: Adverse events/effects
Primary endpoint: spread level in the cranio-caudal direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual and reproductive health knowledge level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with HBsAg below the lower limit of detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bacterial count in dental plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incapacité Totale de Travail
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Predictive capacity of psychomotor development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in visuoconstruction, immediate memory and long-term memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in verbal long-term memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Clinical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary tumor for metastasis of unknown origin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ankle Joint Functional Assessment Tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The modified Star Excursion Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-GD2 antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Win-Track Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-meter Backward walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility as Measured by Percentage of Recruitment Goal Met
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Lost to Attrition During Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Who Report Satisfaction With the MIRA App
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average Number of Treatment Sessions Completed by MIRA App Users
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total Clormadinone: area under the plasma concentration-time curve from 0 to 72 hours (AUC0-72)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Clormadinone: Maximum plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with positive samples
Endpoint domain: Adverse events/effects
Primary endpoint: Knee Range of Motion (Flexion and Extension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Block Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Relative change in SOFA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of antimicrobial agents
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of Problematic Social Media Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Problematic Smartphone Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Internet Gaming Disorder
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Depression and Anxiety Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Real world Objective Response Rate (rwORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in AUC C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Negative predictive value of ddPCR assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: incidence of diabetic ketoacidosis (DKA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of stage 1 pressure ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change in skin temperature at pressure points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change in pain level at pressure points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Tolerability of oral telmisartan
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Prime Diet Quality Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cholesterol metabolism effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bile acid metabolism effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: R0-surgery resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants with clinical significant shifts from baseline in clinical laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Extended Sniffin' Sticks Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of HRV change in response to pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of HRV change in response to pain after exercising
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in GAD-7 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thrombin generation dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PROMIS Sleep-Related Impairment Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Measure Yourself Medical Outcome Profile (MYMOP)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Magnitude of the antibody response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: levels of lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Trapezius muscle and rhomboid muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: fascial sliding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak plasma concentrations (Cmax) of TY-9591 and its metabolites D1 and D2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from 0 to the last quantifiable time point after dose administration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve from 0 to infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical experience in urinary procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total Perioperative Tramadol Consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Generalized anxiety disorder screener GAD-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Impact of Event Stress-Revise
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serological response to the COVID-19 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Suicidal Ideation Questionnaire Junior (SIQ-JR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Suicide Attempt Self-Injury Interview and Count
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative chronic pain: pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical excitability measured by Transcranial Magnetic Stimulation (TMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neural excitability measured by Magnetic resonance imaging (MRI) scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Upper extremity motor function using Fugl-Meyer scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Action Research Arm Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Modified Ashworth scale for spasticity (MAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pediatric International Documentation Committee Subjective (Pedi-IKDC) Knee Form
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Health-related paediatric quality of life (PedsQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: DLMO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BodyTime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PlasmaTime
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image scanning pass rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Emotional Regulation - arousal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Emotional Regulation - recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Slow-wave Activity (SWA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Mass Index change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome of lithium augmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health of Nation Outcome Scale-Secure version (HoNOS-S)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: World Health Organizations Disability Assessment Schedule 2.0
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diaphragm excursion and thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Faulty Breathing Scale (TFBS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cardiac Autonomic Nervous System Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Patients With Clinical Recovery of COVID-19 Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Average Daily Pain Intensity
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Alphabetic Working Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Choice Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Immediate Word Recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Perineal laceration
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Sustained NP Swab SARS-CoV-2 RNA < LLOQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Effective rate of awakening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in KOOS Pain sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area Under the Time-Concentration Curve (AUC0-62) for Serum Pertuzumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Time-Concentration Curve (AUC0-62) for Serum Trastuzumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Serum Concentration (Cmax) of Pertuzumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Serum Concentration (Cmax) of Trastuzumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between self collected samples and traditional venous draws
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical electrophysiology of vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of adverse cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in arterial oxygen partial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SICH (Symptomatic Intracerebral Hemorrhage)
Endpoint domain: Adverse events/effects
Primary endpoint: PBMCs gene expression of miR-382-5p
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reducing rates of suboptimal PCI results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of intrahospital BARC types 3 or 5 bleedings
Endpoint domain: Adverse events/effects
Primary endpoint: apparent clearance of medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Regional Cerebral Oxygen Saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxygen Reserve Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the distance in walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of morphine needed postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline dual-task walking performance at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Montreal Cognitive Assessment (MoCA) score at 8 weeks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Images of neoplastic and non-neoplastic muco-cutaneous conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Total Night Sleep Minutes
Endpoint domain: Life impact
Endpoint subdomain: Sleep